You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR RYBREVANT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for RYBREVANT

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT05379595 ↗	A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer	Not yet recruiting	Janssen Research & Development, LLC	Phase 1/Phase 2	2022-09-19	The purpose of this study is to assess the anti-tumor activity of amivantamab as a monotherapy (Cohorts A, B, and C), to characterize the safety of amivantamab when added to standard-of care (SoC) chemotherapy in participants with metastatic colorectal cancer (mCRC) (Ph2 cohorts), and to assess the recommended phase 2 combination dose (RP2CD) of amivantamab when added to SoC chemotherapy (Ph1b cohorts).
NCT05395052 ↗	FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors	Recruiting	Fate Therapeutics	Phase 1	2022-05-01	This is a Phase 1 dose-finding study of FT536 monotherapy and in combination with monoclonal antibodies.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for RYBREVANT

Condition Name

Chart
Table

Condition Name for RYBREVANT
Intervention	Trials
Advanced or Metastatic Colorectal Cancer	1
Breast Cancer	1
Colorectal Cancer	1
GastroEsophageal Cancer	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for RYBREVANT
Intervention	Trials
Colorectal Neoplasms	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for RYBREVANT

Trials by Country

Map
Table

Trials by Country for RYBREVANT
Location	Trials
United States	8
France	1
Malaysia	1
Belgium	1
Korea, Republic of	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for RYBREVANT
Location	Trials
North Carolina	1
Washington	1
Texas	1
Tennessee	1
New York	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for RYBREVANT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for RYBREVANT
Clinical Trial Phase	Trials
Phase 1/Phase 2	1
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for RYBREVANT
Clinical Trial Phase	Trials
Not yet recruiting	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RYBREVANT

Sponsor Name

Chart
Table

Sponsor Name for RYBREVANT
Sponsor	Trials
Janssen Research & Development, LLC	1
Fate Therapeutics	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for RYBREVANT
Sponsor	Trials
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.